Table 1.

Clinical Features and Outcomes of Primary Malignancy in Giant Cell Tumor of Bone.

No	Gender	Age (y)	Site	Campanacci	Initial Treat	Surgery	Surgical Margin	Pathology	Chemotherapy	Radiation	Recurence	Lung Metastasis	Reoperation	Limb Salvage	Outcome
1	M	18	PF	III	JST	Resection*	Inadequate	UPS	N	N	N	N	N	Y	NED
2	M	40	PT	II	JST	Resection	Adequate	UPS	Y	N	Y	N	Amputation	N	NED
3	M	17	DH	II	Referral	Curettage	Inadequate#	OS	Y	N	Y	N	Resection	Y	NED
4	M	29	DT	II	Referral	Curettage	Inadequate#	OS	Y	N	Y	Y	Amputation	N	Death
5	M	67	DT	II	Referral	Curettage	Inadequate#	OS	N	N	Y	Y	Amputation	N	Death
6	F	20	PF	II	JST	Resection*	Inadequate	UPS	N	N	N	N	N	Y	NED
7	M	21	PT	III	JST	Resection	Adequate	OS	Y	N	Y	Y	Resection	Y	Death
8	M	47	DT	II	Referral	Curettage,	Inadequate#	OS	Y	N	Y	Y	Resection	Y	SWT
9	F	31	DF	III	JST	Curettage, Resection**	Adequate	OS	Y	N	N	N	N	Y	NED
10	F	16	PF	II	JST	Curettage,	Inadequate	OS	N	N	Y	Y	Refuse Surgery	Y	Death
11	F	43	PT	III	JST	Resection	Adequate	FS	N	N	N	N	N	Y	NED
12	F	32	DF	III	JST	Curettage,	Inadequate	OS	Y	N	Y	Y	Amputation	N	Death
PF: Proximal Femur; PT: Proximal Tibia; DH: Distal Humerus; DT: Distal Tibia; DF: Distal Femur; JST: Beijing Jishuitan Hospital; UPS: Undifferentiated pleomorphic sarcoma; OS: Osteosarcoma; FS: Fibrosarcoma; NED: No evidence of disease; SWT: Survival with tumor; *Tumor contamination when resection; **Reoperation in 2 weeks; #Surgery in other hospital.